Thesecross-phenotype associations translate in increased risk of T2D and CAD andhigher CRP levels, at least for the FTO, TMEM18 and MC4R loci (Fig. 2, Table 2, Supplementary Tables 9,12 and 13). This evidence concerns the gene FTO and type 2 diabetes mellitus.